Cargando…
Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer
Pancreatic cancer is an aggressive malignancy and the seventh leading cause of global cancer deaths in industrialised countries. More than 80% of patients suffer from significant weight loss at diagnosis and over time tend to develop severe cachexia. A major cause of weight loss is malnutrition. Pat...
Autores principales: | Pezzilli, Raffaele, Caccialanza, Riccardo, Capurso, Gabriele, Brunetti, Oronzo, Milella, Michele, Falconi, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073203/ https://www.ncbi.nlm.nih.gov/pubmed/31979186 http://dx.doi.org/10.3390/cancers12020275 |
Ejemplares similares
-
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma
por: Trestini, Ilaria, et al.
Publicado: (2021) -
Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM)
por: Silvestris, Nicola, et al.
Publicado: (2020) -
COMMUNI.CARE (COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer): Study Protocol
por: Consolandi, Monica, et al.
Publicado: (2020) -
New era for pancreatic endoscopic ultrasound: From imaging to molecular pathology of pancreatic cancer
por: Archibugi, Livia, et al.
Publicado: (2019) -
Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis
por: Freswick, Peter N., et al.
Publicado: (2022)